MedPath

Early outcome of prenatally diagnosed Ventriculomegaly by general movement Assessment

Not Applicable
Conditions
Ventriculomegaly
Neonatal Diseases
Registration Number
ISRCTN17606645
Lead Sponsor
niversity Medical Center Groningen (Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
24
Inclusion Criteria

1. Newborn child
2. Aged less than one week
3. Having been diagnosed with ventriculomegaly (>10 mm ventricular width) as foetus

Exclusion Criteria

1. Diagnosis of spina bifida
2. First ultrasound at more than 23 weeks of gestation

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> To determine whether the short-term neurological outcome of surviving children diagnosed with prenatally diagnosed ventriculomegaly is associated with the extent of VM before birth.<br><br> The quality of fidgety general movements (FMs) and the motor optimality score (MOS) will be determined at 3 months (11-15 weeks) after term, from video recordings.<br>
Secondary Outcome Measures
NameTimeMethod
<br> To determine whether the etiology of VM and presence of associated anomalies is associated with short-term neurological outcome of children with prenatally diagnosed VM.<br><br> As secondary outcome measure the quality of GMs and the MOS will be assessed at 1 week after birth, and in preterm children (born before 36 weeks) also at term equivalent age (40 weeks ± 14 days post menstrual age), and in all children around 18 weeks (16-20 weeks) after term.<br>
© Copyright 2025. All Rights Reserved by MedPath